What is the new 90-second bowel disease test from Origin Sciences?

The new 90-second test collects a rectal mucus sample to help rule out bowel disease with high accuracy, potentially reducing the need for colonoscopies.

How does the Oricol test differ from a colonoscopy?

The Oricol test is non-invasive and quick, unlike a colonoscopy which requires bowel cleansing, sedation, and insertion of a camera.

Can the Oricol test detect early signs of bowel cancer, according to the study?

Yes, the Oricol test analyzes mucus for genetic and epigenetic markers indicative of colorectal cancers and advanced polyps.

Home / Health / New 90-Second Test Could Revolutionize Bowel Disease Screening

New 90-Second Test Could Revolutionize Bowel Disease Screening

4 Dec, 2025

•

Summary

A rapid 90-second test can rule out bowel disease in 80% of patients.
The non-invasive test collects rectal mucus, avoiding laxatives and sedation.
Developed by Origin Sciences, it could significantly reduce NHS colonoscopy pressure.

New 90-Second Test Could Revolutionize Bowel Disease Screening

A new, rapid 90-second test developed by Origin Sciences offers a significant advancement in bowel disease screening, accurately ruling out the condition in 80% of cases. This non-invasive method collects a small rectal mucus sample, bypassing the discomfort of traditional bowel preparation, laxatives, and sedation associated with colonoscopies. The test analyzes collected material for cancer-linked genetic and epigenetic markers, providing clear biological signals that can distinguish between cancerous conditions, pre-cancerous polyps, and benign issues.